Capital Fund Management (CFM)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-11,500
| Closed | -$8.88M | – | 2473 |
|
|
2025
Q4 | $8.88M | Sell |
11,500
-25,800
| -69% | -$17.5M | 0.02% | 903 |
|
|
2025
Q3 | $21M | Buy |
37,300
+1,700
| +5% | +$961K | 0.06% | 495 |
|
|
2025
Q2 | $18.7M | Sell |
35,600
-13,800
| -28% | -$7.7M | 0.05% | 484 |
|
|
2025
Q1 | $31.3M | Buy |
49,400
+33,300
| +207% | +$22.9M | 0.09% | 311 |
|
|
2024
Q4 | $11.5M | Buy |
+16,100
| New | +$13.5M | 0.03% | 693 |
|
|
2021
Q2 | – | Sell |
-11,400
| Closed | -$5.39M | – | 1611 |
|
|
2021
Q1 | $5.39M | Buy |
+11,400
| New | +$5.55M | 0.06% | 395 |
|
|
2020
Q2 | – | Sell |
-10,500
| Closed | -$5.13M | – | 1464 |
|
|
2020
Q1 | $5.13M | Sell |
10,500
-1,800
| -15% | -$742K | 0.08% | 304 |
|
|
2019
Q4 | $4.62M | Sell |
12,300
-13,800
| -53% | -$4.64M | 0.04% | 563 |
|
|
2019
Q3 | $7.24M | Sell |
26,100
-38,500
| -60% | -$11.4M | 0.07% | 368 |
|
|
2019
Q2 | $20.2M | Buy |
64,600
+51,300
| +386% | +$17.1M | 0.18% | 150 |
|
|
2019
Q1 | $5.46M | Sell |
13,300
-10,200
| -43% | -$4.2M | 0.05% | 463 |
|
|
2018
Q4 | $8.78M | Sell |
23,500
-25,000
| -52% | -$9.15M | 0.08% | 347 |
|
|
2018
Q3 | $19.6M | Sell |
48,500
-44,100
| -48% | -$16.8M | 0.11% | 284 |
|
|
2018
Q2 | $31.9M | Buy |
92,600
+14,300
| +18% | +$4.47M | 0.17% | 176 |
|
|
2018
Q1 | $27M | Buy |
78,300
+6,900
| +10% | +$2.4M | 0.16% | 175 |
|
|
2017
Q4 | $26.8M | Buy |
71,400
+9,500
| +15% | +$3.85M | 0.15% | 167 |
|
|
2017
Q3 | $27.7M | Sell |
61,900
-17,600
| -22% | -$8.37M | 0.2% | 149 |
|
|
2017
Q2 | $39M | Buy |
79,500
+77,000
| +3,080% | +$33.7M | 0.31% | 80 |
|
|
2017
Q1 | $969K | Sell |
2,500
-600
| -19% | -$222K | 0.01% | 927 |
|
|
2016
Q4 | $1.14M | Sell |
3,100
-12,400
| -80% | -$4.72M | 0.01% | 971 |
|
|
2016
Q3 | $6.23M | Sell |
15,500
-27,500
| -64% | -$11M | 0.06% | 406 |
|
|
2016
Q2 | $15M | Buy |
43,000
+32,500
| +310% | +$12.5M | 0.14% | 185 |
|
|
2016
Q1 | $3.79M | Buy |
10,500
+9,000
| +600% | +$3.71M | 0.04% | 521 |
|
|
2015
Q4 | $814K | Sell |
1,500
-3,100
| -67% | -$1.68M | 0.01% | 953 |
|
|
2015
Q3 | $2.14M | Sell |
4,600
-400
| -8% | -$215K | 0.02% | 594 |
|
|
2015
Q2 | $2.55M | Buy |
+5,000
| New | +$2.44M | 0.03% | 545 |
|
|
2014
Q2 | – | Sell |
-8,700
| Closed | -$2.61M | – | 1882 |
|
|
2014
Q1 | $2.61M | Buy |
+8,700
| New | +$2.68M | 0.03% | 578 |
|
|
2013
Q4 | – | Sell |
-7,300
| Closed | -$2.28M | – | 1810 |
|
|
2013
Q3 | $2.28M | Sell |
7,300
-20,000
| -73% | -$5.26M | 0.03% | 598 |
|
|
2013
Q2 | $6.14M | Buy |
+27,300
| New | +$6.36M | 0.09% | 276 |
|
Other funds holding REGN
VCM
N
Capital Fund Management (CFM)'s REGN Position: Q4 2025 in Review
Capital Fund Management (CFM) sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 58,834 shares — an estimated $40M sold.
Capital Fund Management (CFM) first reported a position in REGN in Q1 2014 and held it in 18 quarters. The position peaked at $58.9M in Q1 2025. 1,385 funds tracked by Wall St. Rank hold REGN as of Q4 2025.
- Capital Fund Management (CFM) reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Capital Fund Management (CFM) sold 58,834 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $40M.
- Capital Fund Management (CFM) first reported a position in Regeneron Pharmaceuticals in Q1 2014 and held it in 18 quarters.
- Capital Fund Management (CFM)'s Regeneron Pharmaceuticals position peaked at $58.9M in Q1 2025.
- 1,385 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.
Based on Capital Fund Management (CFM)'s 13F filing for Q4 2025, filed 17 Feb 2026.